US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1300
  • +0.0064+5.18%
Close Nov 21 16:00 ET
  • 0.1276
  • -0.0024-1.85%
Post 19:59 ET
7.47MMarket Cap-2P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

CNS Pharmaceuticals Earnings Reports

  • CNS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 14 17:07 ET

  • CNS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 14 17:26 ET

  • CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2024 Financial Results Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025

    May 16 11:01 ET

  • CNS Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 15 17:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 10, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data